Adial Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Adial Pharmaceuticals, Inc. (ADIL) had Operating Lease Right-of-Use Assets of $180.23 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-05-12
- 2023-03-31: Operating Lease, Right-of-Use Asset $180.23K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $194.00K.
- 2022-09-30: Operating Lease, Right-of-Use Asset $207.47K.
- 2022-06-30: Operating Lease, Right-of-Use Asset $220.66K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-03-31 | $180.23K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $194.00K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $207.47K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $220.66K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $233.57K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $246.21K 10-K · filed 2023-03-30 |
| 2021-09-30 | $258.59K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $270.73K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $282.63K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |